JP2020530857A5 - - Google Patents

Download PDF

Info

Publication number
JP2020530857A5
JP2020530857A5 JP2020509441A JP2020509441A JP2020530857A5 JP 2020530857 A5 JP2020530857 A5 JP 2020530857A5 JP 2020509441 A JP2020509441 A JP 2020509441A JP 2020509441 A JP2020509441 A JP 2020509441A JP 2020530857 A5 JP2020530857 A5 JP 2020530857A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
cbd
effective amount
symptoms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020509441A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530857A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2018/056090 external-priority patent/WO2019034985A1/en
Publication of JP2020530857A publication Critical patent/JP2020530857A/ja
Publication of JP2020530857A5 publication Critical patent/JP2020530857A5/ja
Priority to JP2023087510A priority Critical patent/JP7590803B2/ja
Priority to JP2024197147A priority patent/JP2025024068A/ja
Pending legal-status Critical Current

Links

JP2020509441A 2017-08-14 2018-08-13 経皮カンナビジオールゲルを用いた変形性関節症の治療方法 Pending JP2020530857A (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023087510A JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762545468P 2017-08-14 2017-08-14
US62/545,468 2017-08-14
US201862661733P 2018-04-24 2018-04-24
US62/661,733 2018-04-24
PCT/IB2018/056090 WO2019034985A1 (en) 2017-08-14 2018-08-13 METHODS OF TREATING ARTHROSIS USING CANNABIDIOL TRANSDERMAL GEL

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023087510A Division JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Publications (2)

Publication Number Publication Date
JP2020530857A JP2020530857A (ja) 2020-10-29
JP2020530857A5 true JP2020530857A5 (enExample) 2021-09-30

Family

ID=65362584

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020509441A Pending JP2020530857A (ja) 2017-08-14 2018-08-13 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2023087510A Active JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A Pending JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023087510A Active JP7590803B2 (ja) 2017-08-14 2023-05-29 経皮カンナビジオールゲルを用いた変形性関節症の治療方法
JP2024197147A Pending JP2025024068A (ja) 2017-08-14 2024-11-12 経皮カンナビジオールゲルを用いた変形性関節症の治療方法

Country Status (11)

Country Link
US (4) US20200170963A1 (enExample)
EP (1) EP3668500A4 (enExample)
JP (3) JP2020530857A (enExample)
KR (1) KR20200054171A (enExample)
AU (2) AU2018318425A1 (enExample)
BR (1) BR112020003025A2 (enExample)
CA (1) CA3072849A1 (enExample)
IL (2) IL301622A (enExample)
JO (1) JOP20200031A1 (enExample)
MX (1) MX2020001768A (enExample)
WO (1) WO2019034985A1 (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3668500A4 (en) * 2017-08-14 2021-04-28 Zynerba Pharmaceuticals, Inc. METHOD OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL
HUE058102T2 (hu) 2017-09-28 2022-07-28 Zynerba Pharmaceuticals Inc Fragilis X szindróma és autizmus kezelése kannabidiollal
CA3122735A1 (en) 2018-12-14 2020-06-18 Zynerba Pharmaceuticals, Inc. Treatment of 22q11.2 deletion syndrome with cannabidiol
US12409131B2 (en) 2019-10-03 2025-09-09 Pike Therapeutics Usa, Inc. Transdermal delivery of dronabinol
CA3156257A1 (en) 2019-10-03 2021-04-08 Starton Therapeutics, Inc. TRANSDERMAL DELIVERY OF DRONABINOL
US12016829B2 (en) 2019-10-11 2024-06-25 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
US12186280B2 (en) 2019-10-11 2025-01-07 Pike Therapeutics Inc. Pharmaceutical composition and method for treating seizure disorders
US20220395572A1 (en) * 2019-10-13 2022-12-15 Figene, Llc Cannabidiol adjuvant therapy for treatment of disc degenerative disease
US12268699B2 (en) 2019-10-14 2025-04-08 Pike Therapeutics Inc. Transdermal delivery of tetrahydrocannabinol
MX2022004258A (es) 2019-10-14 2022-05-26 Pike Therapeutics Inc Entrega transdermica de cannabidiol.
US12121617B2 (en) 2019-10-14 2024-10-22 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
MX2022016536A (es) * 2020-06-29 2023-03-15 Zynerba Pharmaceuticals Inc Tratamiento del síndrome de x frágil con cannabidiol.
AU2022257344A1 (en) * 2021-04-12 2023-10-26 Pike Therapeutics Inc. Transdermal delivery of cannabidiol
EP4098254A1 (en) * 2021-06-04 2022-12-07 Assistance Publique, Hopitaux De Paris Cannabidiol for use in the treatment of pain resulting from an indoleamine 2,3-dioxygenase-1 (ido1) related disease
JP2025535174A (ja) * 2022-10-17 2025-10-22 インベンテージ ラボ インコーポレイテッド 炎症性疾患の治療または予防のための徐放型注射用組成物およびその製造方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
GB2414933B (en) * 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
EP1890727B1 (en) * 2005-05-25 2012-10-03 CaloSyn Pharma, Inc Method and composition for treating osteoarthritis
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
KR101799264B1 (ko) * 2008-12-22 2017-11-20 더 유니버시티 오브 멜버른 골관절염 치료
US20100273895A1 (en) * 2009-04-28 2010-10-28 Alltranz Inc. Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same
CA2760128A1 (en) * 2009-04-29 2010-11-04 University Of Kentucky Research Foundation Cannabinoid-containing compositions and methods for their use
US20110052694A1 (en) * 2009-08-31 2011-03-03 Alltranz Inc. Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
CN104704111A (zh) * 2012-06-26 2015-06-10 安柏定企业有限公司 通过超声空化从脂肪组织分离干细胞及使用方法
EP3177286A4 (en) * 2014-07-18 2018-05-16 Medipath Inc. Compositions and methods for physiological delivery using cannabidiol
EP3668500A4 (en) * 2017-08-14 2021-04-28 Zynerba Pharmaceuticals, Inc. METHOD OF TREATMENT OF OSTEOARTHRITIS WITH TRANSDERMAL CANNABIDIOL GEL

Similar Documents

Publication Publication Date Title
JP2020530857A5 (enExample)
JP2023109969A5 (enExample)
CN101417060B (zh) 一种治疗外伤、跌打、斑秃及烧烫伤的药膏
JOP20200031A1 (ar) طرق لعلاج الالتهاب العظمي المفصلي باستخدام هلام من كانابيديول عبر الأدمة
RU2012148710A (ru) Органическое соединение для применения при лечении рака печени
RU2014150942A (ru) Лечение побочных эффектов в виде моторных и двигательных расстройств, связанных с лечением болезни паркинсона
RU2015103107A (ru) Комбинированная композиция
CN104257970B (zh) 一种外用跌打药膏
JP2016505050A5 (enExample)
JP2019529569A5 (enExample)
CN103432551B (zh) 一种治疗肩周炎、网球肘、莫名骨痛的外敷药物
RU2018130097A (ru) Лечение экземы кистей
CN103638155B (zh) 治疗足跟痛的外用中药制剂
CN104800286A (zh) 可增强活血化瘀功效的载药针灸针及其应用
CN105267577B (zh) 一种治疗流行性腮腺炎的贴膏及其制备方法
CN103142923B (zh) 一种治疗冠心病的复方蒙药制剂
BR112017022478A2 (pt) composição farmacêutica de liberação sustentada que contém rivastigmina
CN101837068B (zh) 椒目仁油喷雾剂的制备工艺和应用
CN104800763B (zh) 一种活血化瘀的载药针灸针
CN105596504A (zh) 一种外敷双柏散及其制备方法
CN102772472A (zh) 一种治疗寻常疣的酊剂药物
CN104721254A (zh) 一种愈肤生肌膏
RU2539422C1 (ru) Способ лечения кариеса зубов
CN102512650A (zh) 一种治疗面神经麻痹的外用药物
CN108619210A (zh) 促进伤口愈合的组合物及其制备方法和应用